About Vortex Biosciences
Vortex Biosciences is a company based in Menlo Park (United States) founded in 2012 was acquired by EMV Capital in March 2019. Vortex Biosciences has raised $4.08 million across 2 funding rounds from investors including EMV Capital and EMV Capital. Vortex Biosciences offers products and services including VTX-1 Liquid Biopsy System. Vortex Biosciences operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vortex Biosciences Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.08 M (USD)
in 2 rounds
-
Latest Funding Round
$4.08 M (USD), Seed
Jun 22, 2023
-
Investors
EMV Capital
& 1 more
-
Employee Count
Not available
-
Acquired by
EMV Capital
(Mar 25, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vortex Biosciences
Vortex Biosciences offers a comprehensive portfolio of products and services, including VTX-1 Liquid Biopsy System.
Automates capture of circulating tumor cells from blood for research.
People of Vortex Biosciences
Unlock access to complete
Unlock access to complete
Chairman Team
1 people
Advisor Team
1 people
Leadership Team
1 people
Operations Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Vortex Biosciences
Vortex Biosciences has successfully raised a total of $4.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.08 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vortex Biosciences
Vortex Biosciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include EMV Capital and EMV Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
B2B-tech focused VC firm
|
Locked | Locked | Locked | |
|
Venture capital investments are made in deep tech and life sciences by EMV Capital.
|
Locked | Locked | Locked |
Investor details for Vortex Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vortex Biosciences
Investment portfolio details for Vortex Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vortex Biosciences
Detailed financials for Vortex Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vortex Biosciences Comparisons
Peer comparison for Vortex Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vortex Biosciences
Vortex Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Vortex Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vortex Biosciences
Complete news archive for Vortex Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vortex Biosciences
Vortex Biosciences was founded in 2012 and raised its 1st funding round 10 years after it was founded.
Vortex Biosciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Vortex Biosciences is a funded company, having raised a total of $4.08M across 2 funding rounds to date.
Vortex Biosciences was founded in 2012 in Menlo Park, United States, within the biotechnology sector focused on diagnostics. A liquid biopsy system known as VTX-1 is offered to automate the isolation and collection of circulating tumor cells from blood samples. These cells are released from reservoirs and gathered downstream for additional assays in clinical applications. Operations center on enabling further analysis of tumor cells for medical diagnostics.
Vortex Biosciences's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Vortex Biosciences offers VTX-1 Liquid Biopsy System.
Vortex Biosciences has 2 investors. Key investors include EMV Capital, and EMV Capital.